Clinical trials present a complex landscape that demands meticulous navigation through the intricacies of protocol development, regulatory compliance,...
The World Health Organization states that nearly 39 million people live with HIV/AIDS globally (2022), with 630,000 people dying due to HIV related ca...
Navitas Life Sciences will be at the Parkinson’s Foundation and Parkinson Study Group Annual Conference 2023 Patient registries are vital tools, orchestrating the collection of clinical data to advance the understanding and treatment of various conditions. We are delighted to be sponsoring the upcoming Future of Parkinson’s Disease: I...
Navitas Life Sciences boasts extensive experience in Clinical Data Services, covering a spectrum of crucial aspects including Data Management, Biostatistics & Programming, Data Standardization, Medical Writing, and Submissions. We are dedicated to delivering high-quality clinical trial data management while adhering to rigorous regulatory stand...
As we join the World Health Organization in observing the World Diabetes Day on November 14th, 2023, the global community faces an escalating diabetes crisis, demanding revolutionary advancements in therapeutic solutions. In this spirit, Navitas Life Sciences offers strategic partnerships to pharmaceutical companies, both large and small, in their ...
Dr Narendra Chirmule Director of Biological Sciences at Symphony Technology In this exciting blog, we have the privilege of hearing from a seasoned expert, Dr Narendra Chirmule, PhD who has dedicated decades to advancing our understanding of immunology and pushing the boundaries of drug development. Dr Chirmule is a Director of Biological Sciences ...
In our latest blog, Dr Philipp Hofmann, Director - Pharmacovigilance & QPPV, explores the significance of medication analysis, particularly for older patients in Germany. Offering a professional assessment, this analysis addresses crucial questions regarding potential adverse drug reactions and interactions. Dr Hofmann provides a comprehensive ...
In the ever-evolving landscape of Pharmacovigilance (PV), a parallel momentum is gaining traction — the imperative for transparency and heightened responsibility towards ensuring patient safety. Organizations operating in PV are now facing heightened pressure to demonstrate tangible progress. Transparency is the need of the hour. As we stand...
In a rapidly evolving clinical research landscape, decentralized clinical trials (DCTs) have emerged as a transformative approach, providing an efficient way to conduct clinical trials. To explore the unique capabilities at Navitas Life Sciences, we interviewed Dr Atul Gupta, Vice President – Medical Services and Client Solutions and Dr Akas...
Dr. Ayaaz Hussain Khan, Global Head of Generics at Navitas Life Sciences, will be a distinguished presence at CPHI 2023. With a wealth of experience and vast expertise, Dr. Khan will be present to find solutions for your unique needs and to provide a glimpse into the future of generics. In this blog, we spoke to Dr. Khan, to ask what CPHI North Bar...
Navitas Life Sciences will showcase as a strategic partner at the upcoming SCDM Live Annual Conference – The Festival of Clinical Data Science, between 08 - 11 October 2023 in the Hilton San Diego Bayfront, San Diego, CA, USA. Our team of experts will be present to discuss insights that will transform your Clinical Data landscape. In this bl...
Navitas Life Sciences, a trusted global CRO, will be participating in the highly anticipated World Drug Safety Congress events in both America and Europe. With a legacy of excellence in pharmacovigilance, we will be present to discuss how we can support your PV needs with our expert insights and vast experience. Elevating Drug Safety Through Expert...